Role of Complement C5a/C3a agonists existing broadly in animals and plants
Role of Complement C5a/C3a agonists existing broadly in animals and plants
批准号:
09660084
负责人:
YOSHIKAWA Masaaki
金额:
$2.18万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
补体C3a从补体C3的氨基端区释放,引起平滑肌的炎症和收缩。我们发现补体C3a具有抗镇痛和抗健忘症等中枢作用。从酪蛋白、大米白蛋白、血红蛋白、血清白蛋白和组蛋白的胰蛋白酶消化液中分离到的低分子量C3a激动剂在其羧基端、疏水残基- x_1 - leu - x_2 - arg上具有共同的序列。这些肽可能与C3a受体结合,因为其序列与C3a的羧基端相同。在一些内源性生物活性肽的一级结构中发现了类似的肽。这类多肽不仅广泛存在于动物中,也广泛存在于植物中,因此只有一部分可能具有生理意义。补体C5a也从补体C5的氨基端区释放,具有与C3a相同的强大生物活性。从猪血清白蛋白中释放的白蛋白A (ala - ph - lys - ala - trp - ser - leu - ala - arg)可结合C3a和C5a受体。另一方面,乳铁蛋白释放的ph - lys - asp - cys - his - leu - ala - arg与C5a受体结合。由于C5a的羧基末端结构为Lys- asp - met - gln - leu - gly - arg,因此在羧基末端的第7个残基上的Lys似乎对C5a受体的亲和力至关重要。因此,C3a和C5a激动剂广泛存在于动物和植物中。其中一些有望用作药品或食品,以改善我们的健康。
英文摘要
Complement C3a which is released from the amino-terminus region of Complement C3 induces inflammation and contraction of smooth muscle. We found that Complement C3a shows central effects such as anti-analgesia and anti-amnesia. Low molecular weight C3a agonists we isolated from tryptic digests of casein, rice albumin, hemoglobin, serum albumin and histone have common sequence at their carboxyl termini, hydrophobic residue-X_1-Leu-X_2-Arg. These peptides might bind C3a receptor because the sequence is common to that at the carboxyl terminus of C3a. Similar peptides were found in the primary structure of some endogenous bioactive peptides. Only a part of such peptides might have' physiological significance because such peptides are found broadly not only in animals but also in plants.Complement C5a which is also released from the amino-terminus region of Complement C5 has potent biological activities common to those of C3a. Albutensin A, Ala-Phe-Lys-Ala-Trp-Ser-Leu-Ala-Arg, which is released from porcine serum albumin binds both C3a and C5a receptors. On the other hand, Phe-Lys-Asp-Cys-His-Leu-Ala-Arg, which is released from lactoferrin binds C5a receptor. The Lys at the 7th residue from the carboxyl terminus seems to be essential for C5a receptor affinity since the structure at the carboxyl terminus of C5a is Lys-Asp-Met-Gln-Leu-Gly-Arg. Thus, C3a and C5a agonists existing broadly in animal and plants. It is expected to use some of them as pharmaceutical drugs or foods to improve our health.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
YASHIKAWA,M.: "Effects of Tyr-MIF-1 on Stress-induced analgesia and the blockade of development of morphine tolerance by stress." Jap.J.Pharmacol.79(2). 231-235 (1999)
YASHIKAWA,M.:“Tyr-MIF-1 对压力诱导的镇痛和压力阻断吗啡耐受性发展的影响。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Fukudome, S.: "Release of opioid peptides, gluten exorphins by the action of pancreatic elastase." FEBS Lett.412(2). 475-479 (1997)
Fukudome, S.:“通过胰腺弹性蛋白酶的作用释放阿片肽、麸质外啡肽。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takahashi,M.: "Albutensin A,an ileum-contracting peptide derived from serum albumin,acts through both receptors for complements C3a and C5a." Lett.Peptide Sci.4(1). 1-7 (1997)
Takahashi,M.:“Albutensin A 是一种源自血清白蛋白的回肠收缩肽,通过补体 C3a 和 C5a 的两种受体发挥作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
吉川正明: "食品および一般タンパク質から派生する生理活性ぺプチド" 科学と工業. 71(8). 310-316 (1997)
Masaaki Yoshikawa:“源自食品和一般蛋白质的生物活性肽”《科学与工业》71(8) (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
YOSHIKAWA,M.: "Exploitation of foods preventig Lifestyle-related diseases-Physiological engineering of peptides.in Japanese" Gakujyutu no Goko. 3(11). 27-29 (1998)
YOSHIKAWA,M.:“利用食品预防生活方式相关疾病 - 肽的生理工程。日语”Gakujyutu no Goko。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
Approach to axon degeneration of motor neurons using pre-symptomatic ALS model mice
-
批准号:18K06510
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.58万
-
财政年份:2018
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Hair growth-stimulating and anti-alopecia mechanism of low molecular weight peptides
-
批准号:18380081
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.91万
-
财政年份:2006
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Studies on low molecular weight peptides regulating food intake after oral administration
-
批准号:13460057
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:2001
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Exploitation of anti-alopecic and hair-growth promoting peptides
-
批准号:12559005
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.74万
-
财政年份:2000
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Exploitation of effective uses of Rubisco as highly functional food resources
-
批准号:12793007
-
项目类别:Grant-in-Aid for University and Society Collaboration
-
资助金额:$19.58万
-
财政年份:2000
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Bioactive peptides acting on animals and plants
-
批准号:11460045
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$9.09万
-
财政年份:1999
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Exploitation of anti-amnesic drugs based on novel lead substance
-
批准号:09559009
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:1997
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Active Control Effect by Mass Driver System to Urban Important Structures during Earthquake
-
批准号:08650566
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:1996
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Regulation of artery, immune and nervous systems by albutensin derived from serum albumin
-
批准号:07660162
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.66万
-
财政年份:1995
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Design and Improvement of Food Proteins by the Introduction of New Function
-
批准号:03660134
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1991
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Studies Opioid Antagonist Peptides with Retro-Orientation
-
批准号:01560148
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:1989
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
Structures and Functions of Opioid Peptides Derived from Casein.
-
批准号:60560091
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.09万
-
财政年份:1985
-
负责人:YOSHIKAWA Masaaki
-
依托单位:
国内基金
海外基金
登录
查看更多内容
C3a/C3aR信号通路介导MMP表达增高在视
神经脊髓炎谱系疾病发病中的作用及机
制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:杨晖
-
依托单位:
补体通路C3a/C3ar1/STAT3调控Pla2g5介导巨噬细胞-肌成纤维细胞转化在骨骼肌急性损伤后纤维化
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙亚英
-
依托单位:
补体C3a上调NE/GSDMD介导NETs释放参与中轴型脊柱关节炎发病的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2024
-
负责人:李业豪
-
依托单位:
C3a/C3aR轴通过调控PKM2活性影响能量代谢促进糖尿病肾病足细胞损伤的作用机制研究
-
批准号:2023J01091
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2023
-
负责人:万建新
-
依托单位:
补体C3a及其受体通路在糖尿病肾病足细胞损伤中的作用及机制研究
-
批准号:82300815
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:姜世敏
-
依托单位:
化学外加剂作用下C3A水化过程调控机制及对水泥混凝土早期性能的影响
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:卢子臣
-
依托单位:
补体C3a通过YAP启动子区甲基化诱导破骨细胞分化在种植体周围炎骨吸收中的作用机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:刘笑涵
-
依托单位:
老龄化宿主巨噬细胞C3a/C3aR1障碍导致流感肺损伤后肺泡修复调控异常的机制研究
-
批准号:82270010
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:李辉
-
依托单位:
C3a、C5a调控NRF2促进多发性骨髓瘤细胞迁移、侵袭、粘附的机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:熊杰
-
依托单位:
慢性低氧激活补体替代途径通过C3a/C3aR轴促进肺动脉高压机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:朴春梅
-
依托单位: